Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival
byCedars-Sinai Medical CenterGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.08.019Investigators from Cedars-Sinai Cancer have identified an investigati
Updated on: December 26,2023
Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival
byCedars-Sinai Medical CenterGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.08.019Investigators from Cedars-Sinai Cancer have identified an investigati
Updated on:December 26,2023
